Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo
- Author
- SANDRINE ASPESLAGH (UGent) , YaLi Li, Esther Dawen Yu, Nora Pauwels (UGent) , Matthias Trappeniers (UGent) , Enrico Girardi, Tine Decruy (UGent) , Katrien Van Beneden (UGent) , Koen Venken (UGent) , Michael Drennan (UGent) , Luc Leybaert (UGent) , Jing Wang, Serge Van Calenbergh (UGent) , Dirk M Zajonc and Dirk Elewaut (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-1976027
- MLA
- ASPESLAGH, SANDRINE, et al. “Galactose Modified INKT Cell Agonists Stabilised by a Novel Structural Modification of CD1D Lead to Marked TH1 Polarisation in Vivo.” ANNALS OF THE RHEUMATIC DISEASES, vol. 70, no. suppl. 2, 2011, pp. A53–A53, doi:10.1136/ard.2010.148981.26.
- APA
- ASPESLAGH, S., Li, Y., Yu, E. D., Pauwels, N., Trappeniers, M., Girardi, E., … Elewaut, D. (2011). Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo. ANNALS OF THE RHEUMATIC DISEASES, 70(suppl. 2), A53–A53. https://doi.org/10.1136/ard.2010.148981.26
- Chicago author-date
- ASPESLAGH, SANDRINE, YaLi Li, Esther Dawen Yu, Nora Pauwels, Matthias Trappeniers, Enrico Girardi, Tine Decruy, et al. 2011. “Galactose Modified INKT Cell Agonists Stabilised by a Novel Structural Modification of CD1D Lead to Marked TH1 Polarisation in Vivo.” In ANNALS OF THE RHEUMATIC DISEASES, 70:A53–A53. https://doi.org/10.1136/ard.2010.148981.26.
- Chicago author-date (all authors)
- ASPESLAGH, SANDRINE, YaLi Li, Esther Dawen Yu, Nora Pauwels, Matthias Trappeniers, Enrico Girardi, Tine Decruy, Katrien Van Beneden, Koen Venken, Michael Drennan, Luc Leybaert, Jing Wang, Serge Van Calenbergh, Dirk M Zajonc, and Dirk Elewaut. 2011. “Galactose Modified INKT Cell Agonists Stabilised by a Novel Structural Modification of CD1D Lead to Marked TH1 Polarisation in Vivo.” In ANNALS OF THE RHEUMATIC DISEASES, 70:A53–A53. doi:10.1136/ard.2010.148981.26.
- Vancouver
- 1.ASPESLAGH S, Li Y, Yu ED, Pauwels N, Trappeniers M, Girardi E, et al. Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo. In: ANNALS OF THE RHEUMATIC DISEASES. 2011. p. A53–A53.
- IEEE
- [1]S. ASPESLAGH et al., “Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo,” in ANNALS OF THE RHEUMATIC DISEASES, Amsterdam, The Netherlands, 2011, vol. 70, no. suppl. 2, pp. A53–A53.
@inproceedings{1976027,
author = {{ASPESLAGH, SANDRINE and Li, YaLi and Yu, Esther Dawen and Pauwels, Nora and Trappeniers, Matthias and Girardi, Enrico and Decruy, Tine and Van Beneden, Katrien and Venken, Koen and Drennan, Michael and Leybaert, Luc and Wang, Jing and Van Calenbergh, Serge and Zajonc, Dirk M and Elewaut, Dirk}},
booktitle = {{ANNALS OF THE RHEUMATIC DISEASES}},
issn = {{0003-4967}},
language = {{eng}},
location = {{Amsterdam, The Netherlands}},
number = {{suppl. 2}},
pages = {{A53--A53}},
title = {{Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo}},
url = {{http://doi.org/10.1136/ard.2010.148981.26}},
volume = {{70}},
year = {{2011}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: